ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Zeposia 0.46 mg, Hartkapseln - 
67046003 Bristol-Myers Squibb SA
Zeposia 0.46 mg, Hartkapseln11.08.2020
  11.08.2020
Ozanimod (L04AA38) 
WHO-DDD10.08.2025
01.99. 
01.99. 
B  
No 
IP 
PR  
k.A.PR
  
7680670460033Synthetika
  
Composition
ozanimodum 0.46 mg ut ozanimodi hydrochloridum 0.5 mg, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium max. 0.187 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172, pro capsula.
Packungsbestandteile
Capsules
 
Active AgentDose
Ozanimodum0.46 mg
 
Inactive agents additional_information
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
Source
Data was imported : 06.10.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home